The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

Clinical trial NCT01821911 · COMPLETED

Trial details

NCT number: NCT01821911
Sponsor: Beijing Center for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rabies Vaccine Allergy Vaccination Adverse Event Anti-D Antibodies

Start date: 2012-07-01
Primary completion: 2013-12-01
Enrollment: 10500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.